{
    "clinical_study": {
        "@rank": "13202", 
        "arm_group": [
            {
                "arm_group_label": "CBT", 
                "arm_group_type": "Experimental", 
                "description": "Cognitive Behavioral Therapy"
            }, 
            {
                "arm_group_label": "Behavioral Modification", 
                "arm_group_type": "Sham Comparator", 
                "description": "Standard sleep hygiene education/desensitization therapy"
            }
        ], 
        "brief_summary": {
            "textblock": "To establish with a prospective randomized placebo-controlled study the feasibility of\n      allied-health personnel-administered cognitive behavioral insomnia therapy (CBTI) as a means\n      of improving HIV/AIDS treatment adherence."
        }, 
        "brief_title": "Feasibility of Non-pharmacological Insomnia Therapy in People Living With HIV", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Insomnia", 
            "Sleep Efficiency"
        ], 
        "condition_browse": {
            "mesh_term": "Sleep Initiation and Maintenance Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  provide documentation of HIV seropositivity, and have been on current HAART (Highly\n             Active AntiRetroviral Therapy) or antiretroviral regimen without any foreseeable\n             reason to discontinue the HAART during the course of the study;\n\n          -  males or females age 18-75 years of age;\n\n          -  \u22653 month history of insomnia meeting standard psychiatric criteria for insomnia based\n             on DSISD;\n\n          -  sleep onset latency (SOL) and/or wake after sleep onset (WASO) greater than 30\n             minutes, with a corresponding sleep time of less than 6.5 hours at least 3 nights per\n             week (as measured by the 7-day sleep diary);\n\n          -  be able to read, understand, and sign an informed consent form before entering into\n             the study and must be willing to comply with all study procedures as well as to agree\n             to participate for the entire study period.\n\n        Exclusion Criteria:\n\n          -  use of any medication with a significant effect on sleep/wake function within 5\n             half-lives of baseline or during the study including hypnotics, over-the-counter\n             sleep aides, sedating antidepressants or sedating anxiolytics;\n\n          -  history or DSISD (Duke Insomnia Sleep Diagnostics) suggests sleep disorder other than\n             insomnia (e.g., sleep apnea, narcolepsy, periodic leg movements, etc.), or have\n             insomnia associated with circadian rhythm disturbances, such as night or rotating\n             shift work or travel across more than four time zones in the 14 days before Initial\n             Screening (Visit 1) or during the study;\n\n          -  clinically significant unstable medical or psychiatric condition, or have any\n             clinically significant abnormal finding in physical examination, neurological\n             assessment, or vital signs, as determined by the Investigator;\n\n          -  self reports typical consumption of more than five alcoholic beverages on a single\n             day or greater than 14 alcoholic beverages weekly at Initial Screening (Visit 1);\n\n          -  have used any investigational drug within 30 days or five half-lives (whichever is\n             longer) prior to Initial Screening (Visit 1), or plans to use an investigational drug\n             during the study;\n\n          -  unable to give informed consent or comply with study procedures."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01804907", 
            "org_study_id": "Pro00032846"
        }, 
        "intervention": [
            {
                "arm_group_label": "CBT", 
                "intervention_name": "Cognitive Behavioral Therapy", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Behavioral Modification", 
                "intervention_name": "Behavioral Modification", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "HAART adherence", 
            "HIV", 
            "Fatigue", 
            "treatment"
        ], 
        "lastchanged_date": "May 19, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Durham", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27710"
                }, 
                "name": "Duke University"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Patients evaluated weekly for change in sleep efficiency.", 
            "measure": "Sleep Efficiency", 
            "safety_issue": "No", 
            "time_frame": "Week 1, 2,3, and 4"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01804907"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Evaluated once weekly for changes in medication adherence.", 
                "measure": "Adherence to HAART", 
                "safety_issue": "No", 
                "time_frame": "Week 1, 2,3, and 4"
            }, 
            {
                "description": "Changes in reported fatigue levels measured weekly, via the Paper Fatigue Scale (PFS), and the HIV-Related Fatigue Scale (HRFS).", 
                "measure": "Fatigue", 
                "safety_issue": "No", 
                "time_frame": "Week 1, 2,3, and 4"
            }
        ], 
        "source": "Duke University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Duke University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}